CA2560521C - Compositions destinees a l'identification de bacteries - Google Patents

Compositions destinees a l'identification de bacteries Download PDF

Info

Publication number: CA2560521C
Authority: CA; Canada
Prior art keywords: data; primer; triphosphate; primers; seq
Prior art date: 2004-02-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA2560521A

Other languages

English (en)

Other versions

CA2560521A1 (fr

Inventor

Rangarajan Sampath

Thomas A. Hall

David J. Ecker

Mark W. Eshoo

Christian Massire

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ibis Biosciences Inc

Original Assignee

Ibis Biosciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-18

Filing date

2005-02-18

Publication date

2012-01-03

2005-02-18 Application filed by Ibis Biosciences Inc filed Critical Ibis Biosciences Inc

2006-07-06 Publication of CA2560521A1 publication Critical patent/CA2560521A1/fr

2012-01-03 Application granted granted Critical

2012-01-03 Publication of CA2560521C publication Critical patent/CA2560521C/fr

2025-02-18 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title claims abstract description 182
241000894006 Bacteria Species 0.000 title abstract description 33
108091034117 Oligonucleotide Proteins 0.000 claims description 42
230000002441 reversible effect Effects 0.000 claims description 30
239000001226 triphosphate Substances 0.000 claims description 10
OOMLBPVHGFQCCL-RRKCRQDMSA-N 5-iododeoxycytidine triphosphate Chemical compound C1=C(I)C(N)=NC(=O)N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 OOMLBPVHGFQCCL-RRKCRQDMSA-N 0.000 claims description 3
BUZOGVVQWCXXDP-VPENINKCSA-N 8-oxo-dGTP Chemical compound O=C1NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 BUZOGVVQWCXXDP-VPENINKCSA-N 0.000 claims description 3
RLYLTZXYBNQTOL-UBKIQSJTSA-N [(2r,3s,5r)-3-hydroxy-5-(5-hydroxy-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl [hydroxy(phosphonooxy)phosphoryl] hydrogen phosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C(O)=C1 RLYLTZXYBNQTOL-UBKIQSJTSA-N 0.000 claims description 3
IUHVPBMWOOKUDM-KVQBGUIXSA-N [[(2r,3s,5r)-5-(2,4-dioxo-1,3,5-triazin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)N=C1 IUHVPBMWOOKUDM-KVQBGUIXSA-N 0.000 claims description 3
UYPHYZSNRPGPAN-RRKCRQDMSA-N [[(2r,3s,5r)-5-(4-amino-5-bromo-2-oxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C1=C(Br)C(N)=NC(=O)N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 UYPHYZSNRPGPAN-RRKCRQDMSA-N 0.000 claims description 3
BLQCQNFLEGAHPA-RRKCRQDMSA-N [[(2r,3s,5r)-5-(5-bromo-2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C(Br)=C1 BLQCQNFLEGAHPA-RRKCRQDMSA-N 0.000 claims description 3
YQOCUTDPKPPQGA-RRKCRQDMSA-N [[(2r,3s,5r)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C(F)=C1 YQOCUTDPKPPQGA-RRKCRQDMSA-N 0.000 claims description 3
ZWDWDTXYXXJLJB-RRKCRQDMSA-N [hydroxy-[[(2r,3s,5r)-3-hydroxy-5-(5-iodo-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] phosphono hydrogen phosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C(I)=C1 ZWDWDTXYXXJLJB-RRKCRQDMSA-N 0.000 claims description 3
LZAPTRCZOHFNTH-XLPZGREQSA-N [hydroxy-[[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2-oxo-4-sulfanylidenepyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] phosphono hydrogen phosphate Chemical compound O=C1NC(=S)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 LZAPTRCZOHFNTH-XLPZGREQSA-N 0.000 claims description 3
WACSOCIQBWBECS-RRKCRQDMSA-N [hydroxy-[[(2r,3s,5r)-3-hydroxy-5-[2-(methylamino)-6-oxo-3h-purin-9-yl]oxolan-2-yl]methoxy]phosphoryl] phosphono hydrogen phosphate Chemical compound C1=NC=2C(=O)NC(NC)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 WACSOCIQBWBECS-RRKCRQDMSA-N 0.000 claims description 3
230000003321 amplification Effects 0.000 abstract description 89
238000003199 nucleic acid amplification method Methods 0.000 abstract description 89
230000001580 bacterial effect Effects 0.000 abstract description 65
150000007523 nucleic acids Chemical class 0.000 abstract description 64
102000039446 nucleic acids Human genes 0.000 abstract description 63
108020004707 nucleic acids Proteins 0.000 abstract description 63
238000004458 analytical method Methods 0.000 abstract description 38
239000003155 DNA primer Substances 0.000 abstract description 13
239000013615 primer Substances 0.000 description 396
108091093088 Amplicon Proteins 0.000 description 133
108090000623 proteins and genes Proteins 0.000 description 64
238000000034 method Methods 0.000 description 61
239000000523 sample Substances 0.000 description 53
101000597770 Homo sapiens Tropomodulin-1 Proteins 0.000 description 44
102100035291 Tropomodulin-1 Human genes 0.000 description 44
230000000295 complement effect Effects 0.000 description 39
238000001514 detection method Methods 0.000 description 38
108091033319 polynucleotide Proteins 0.000 description 34
102000040430 polynucleotide Human genes 0.000 description 34
239000002157 polynucleotide Substances 0.000 description 34
241000894007 species Species 0.000 description 34
238000002603 single-photon emission computed tomography Methods 0.000 description 31
238000003752 polymerase chain reaction Methods 0.000 description 28
241000193738 Bacillus anthracis Species 0.000 description 27
238000000605 extraction Methods 0.000 description 22
241000193830 Bacillus <bacterium> Species 0.000 description 21
229940065181 bacillus anthracis Drugs 0.000 description 20
238000004949 mass spectrometry Methods 0.000 description 20
230000008569 process Effects 0.000 description 20
102000004169 proteins and genes Human genes 0.000 description 19
102000004167 Ribonuclease P Human genes 0.000 description 18
108090000621 Ribonuclease P Proteins 0.000 description 18
241000589877 Campylobacter coli Species 0.000 description 17
241000191967 Staphylococcus aureus Species 0.000 description 17
238000006243 chemical reaction Methods 0.000 description 17
125000003729 nucleotide group Chemical group 0.000 description 17
241000588724 Escherichia coli Species 0.000 description 16
241000193996 Streptococcus pyogenes Species 0.000 description 16
241000607479 Yersinia pestis Species 0.000 description 16
108020004418 ribosomal RNA Proteins 0.000 description 16
244000052769 pathogen Species 0.000 description 15
108020004465 16S ribosomal RNA Proteins 0.000 description 14
241000588722 Escherichia Species 0.000 description 13
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
239000002773 nucleotide Substances 0.000 description 12
239000013612 plasmid Substances 0.000 description 12
241001505901 Streptococcus sp. 'group A' Species 0.000 description 11
208000015181 infectious disease Diseases 0.000 description 11
150000002500 ions Chemical class 0.000 description 11
241000589291 Acinetobacter Species 0.000 description 10
241001646722 Mycobacterium tuberculosis CDC1551 Species 0.000 description 10
101100145480 Prochlorococcus marinus (strain SARG / CCMP1375 / SS120) rpoC2 gene Proteins 0.000 description 10
241000191940 Staphylococcus Species 0.000 description 10
238000001819 mass spectrum Methods 0.000 description 10
101150109946 rpo1C gene Proteins 0.000 description 10
101150090202 rpoB gene Proteins 0.000 description 10
101150042391 rpoC gene Proteins 0.000 description 10
101150103066 rpoC1 gene Proteins 0.000 description 10
241000589875 Campylobacter jejuni Species 0.000 description 9
101100038261 Methanococcus vannielii (strain ATCC 35089 / DSM 1224 / JCM 13029 / OCM 148 / SB) rpo2C gene Proteins 0.000 description 9
108700043532 RpoB Proteins 0.000 description 9
210000004027 cell Anatomy 0.000 description 9
230000000241 respiratory effect Effects 0.000 description 9
101150015255 rplB gene Proteins 0.000 description 9
101150085857 rpo2 gene Proteins 0.000 description 9
239000013598 vector Substances 0.000 description 9
108020004414 DNA Proteins 0.000 description 8
108700039887 Essential Genes Proteins 0.000 description 8
241000588653 Neisseria Species 0.000 description 8
230000015572 biosynthetic process Effects 0.000 description 8
238000012163 sequencing technique Methods 0.000 description 8
ACWBQPMHZXGDFX-QFIPXVFZSA-N valsartan Chemical compound C1=CC(CN(C(=O)CCCC)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=CC=C1C1=NN=NN1 ACWBQPMHZXGDFX-QFIPXVFZSA-N 0.000 description 8
241000588626 Acinetobacter baumannii Species 0.000 description 7
241000589876 Campylobacter Species 0.000 description 7
208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 7
206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 7
241000700605 Viruses Species 0.000 description 7
101100313718 Bacillus subtilis (strain 168) mmgA gene Proteins 0.000 description 6
241001453380 Burkholderia Species 0.000 description 6
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 6
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 6
101100399876 Homo sapiens LRRC26 gene Proteins 0.000 description 6
238000007476 Maximum Likelihood Methods 0.000 description 6
108010049395 Prokaryotic Initiation Factor-2 Proteins 0.000 description 6
102100022842 Structural maintenance of chromosomes protein 4 Human genes 0.000 description 6
101150056072 TUFB gene Proteins 0.000 description 6
239000011324 bead Substances 0.000 description 6
238000004364 calculation method Methods 0.000 description 6
101150118250 capC gene Proteins 0.000 description 6
238000013461 design Methods 0.000 description 6
238000010586 diagram Methods 0.000 description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
-1 elongation factors Proteins 0.000 description 6
238000012986 modification Methods 0.000 description 6
230000004048 modification Effects 0.000 description 6
101150013854 mutS gene Proteins 0.000 description 6
244000144977 poultry Species 0.000 description 6
101150106760 smc-4 gene Proteins 0.000 description 6
238000003786 synthesis reaction Methods 0.000 description 6
230000001018 virulence Effects 0.000 description 6
101150033098 xpt gene Proteins 0.000 description 6
241000423294 Burkholderia pseudomallei K96243 Species 0.000 description 5
241000989743 Chlamydophila pneumoniae J138 Species 0.000 description 5
101100185881 Clostridium tetani (strain Massachusetts / E88) mutS2 gene Proteins 0.000 description 5
241000589242 Legionella pneumophila Species 0.000 description 5
241000186367 Mycobacterium avium Species 0.000 description 5
241001002976 Mycobacterium avium 104 Species 0.000 description 5
241001646725 Mycobacterium tuberculosis H37Rv Species 0.000 description 5
108700035964 Mycobacterium tuberculosis HsaD Proteins 0.000 description 5
241000432072 Mycoplasma pneumoniae M129 Species 0.000 description 5
241000588650 Neisseria meningitidis Species 0.000 description 5
241000320117 Pseudomonas putida KT2440 Species 0.000 description 5
241000315672 SARS coronavirus Species 0.000 description 5
241000194017 Streptococcus Species 0.000 description 5
241000194048 Streptococcus equi Species 0.000 description 5
241000194026 Streptococcus gordonii Species 0.000 description 5
241001521783 Streptococcus mutans UA159 Species 0.000 description 5
241001144198 Streptococcus pneumoniae 670-6B Species 0.000 description 5
241000694196 Streptococcus pneumoniae R6 Species 0.000 description 5
241000683224 Streptococcus pneumoniae TIGR4 Species 0.000 description 5
241000825081 Streptococcus pyogenes MGAS10394 Species 0.000 description 5
241001520169 Streptococcus pyogenes MGAS315 Species 0.000 description 5
241001105409 Streptococcus pyogenes MGAS8232 Species 0.000 description 5
241001455236 Streptococcus pyogenes SSI-1 Species 0.000 description 5
241000320124 Streptococcus pyogenes str. Manfredo Species 0.000 description 5
241000607734 Yersinia <bacteria> Species 0.000 description 5
244000052616 bacterial pathogen Species 0.000 description 5
201000010099 disease Diseases 0.000 description 5
230000006870 function Effects 0.000 description 5
101150117187 glmS gene Proteins 0.000 description 5
238000009396 hybridization Methods 0.000 description 5
229940115932 legionella pneumophila Drugs 0.000 description 5
239000002777 nucleoside Substances 0.000 description 5
101150099542 tuf gene Proteins 0.000 description 5
101150071165 tuf1 gene Proteins 0.000 description 5
101150010742 tuf2 gene Proteins 0.000 description 5
101150112181 valS gene Proteins 0.000 description 5
108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
241001406043 Bordetella pertussis Tohama I Species 0.000 description 4
101100174521 Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110) fumC2 gene Proteins 0.000 description 4
241001607436 Burkholderia cenocepacia J2315 Species 0.000 description 4
241000201562 Chlamydophila pneumoniae AR39 Species 0.000 description 4
241000201569 Chlamydophila pneumoniae CWL029 Species 0.000 description 4
241001065357 Chlamydophila pneumoniae TW-183 Species 0.000 description 4
241000193403 Clostridium Species 0.000 description 4
241001405991 Corynebacterium diphtheriae NCTC 13129 Species 0.000 description 4
238000004252 FT/ICR mass spectrometry Methods 0.000 description 4
241000589602 Francisella tularensis Species 0.000 description 4
241000606768 Haemophilus influenzae Species 0.000 description 4
241001235200 Haemophilus influenzae Rd KW20 Species 0.000 description 4
102000003960 Ligases Human genes 0.000 description 4
108090000364 Ligases Proteins 0.000 description 4
201000009906 Meningitis Diseases 0.000 description 4
241000529648 Neisseria meningitidis MC58 Species 0.000 description 4
241000947238 Neisseria meningitidis serogroup C Species 0.000 description 4
108010044843 Peptide Initiation Factors Proteins 0.000 description 4
102000005877 Peptide Initiation Factors Human genes 0.000 description 4
101100408135 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) phnA gene Proteins 0.000 description 4
241001209206 Pseudomonas fluorescens Pf0-1 Species 0.000 description 4
102000002278 Ribosomal Proteins Human genes 0.000 description 4
108010000605 Ribosomal Proteins Proteins 0.000 description 4
241000750300 Staphylococcus aureus MW2 Species 0.000 description 4
241000344863 Staphylococcus aureus subsp. aureus COL Species 0.000 description 4
241000344861 Staphylococcus aureus subsp. aureus NCTC 8325 Species 0.000 description 4
241001540742 Streptococcus agalactiae NEM316 Species 0.000 description 4
241000320123 Streptococcus pyogenes M1 GAS Species 0.000 description 4
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
101150052825 dnaK gene Proteins 0.000 description 4
230000000694 effects Effects 0.000 description 4
238000000132 electrospray ionisation Methods 0.000 description 4
229940118764 francisella tularensis Drugs 0.000 description 4
101150028420 fumC gene Proteins 0.000 description 4
101150077981 groEL gene Proteins 0.000 description 4
230000002458 infectious effect Effects 0.000 description 4
238000011835 investigation Methods 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
239000000463 material Substances 0.000 description 4
238000005259 measurement Methods 0.000 description 4
230000036961 partial effect Effects 0.000 description 4
230000037452 priming Effects 0.000 description 4
238000001228 spectrum Methods 0.000 description 4
235000011178 triphosphate Nutrition 0.000 description 4
101150044170 trpE gene Proteins 0.000 description 4
108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 description 3
102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 description 3
241000193755 Bacillus cereus Species 0.000 description 3
108050001186 Chaperonin Cpn60 Proteins 0.000 description 3
102000052603 Chaperonins Human genes 0.000 description 3
241000120529 Chenuda virus Species 0.000 description 3
241001112696 Clostridia Species 0.000 description 3
206010011409 Cross infection Diseases 0.000 description 3
108010054814 DNA Gyrase Proteins 0.000 description 3
102000012410 DNA Ligases Human genes 0.000 description 3
108010061982 DNA Ligases Proteins 0.000 description 3
101100221536 Dictyostelium discoideum comA gene Proteins 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
241001446405 Klebsiella pneumoniae MGH 78578 Species 0.000 description 3
101100023384 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) mimG gene Proteins 0.000 description 3
241000988233 Neisseria gonorrhoeae FA 1090 Species 0.000 description 3
241000529650 Neisseria meningitidis Z2491 Species 0.000 description 3
101100220445 Nocardia farcinica (strain IFM 10152) groEL2 gene Proteins 0.000 description 3
101100278084 Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576) dnaK1 gene Proteins 0.000 description 3
241000589516 Pseudomonas Species 0.000 description 3
241001240958 Pseudomonas aeruginosa PAO1 Species 0.000 description 3
241000606701 Rickettsia Species 0.000 description 3
108091081021 Sense strand Proteins 0.000 description 3
238000012300 Sequence Analysis Methods 0.000 description 3
241001026378 Streptococcus mitis NCTC 12261 Species 0.000 description 3
101100117145 Synechocystis sp. (strain PCC 6803 / Kazusa) dnaK2 gene Proteins 0.000 description 3
102000014701 Transketolase Human genes 0.000 description 3
108010043652 Transketolase Proteins 0.000 description 3
239000002253 acid Substances 0.000 description 3
230000006154 adenylylation Effects 0.000 description 3
239000003242 anti bacterial agent Substances 0.000 description 3
229940088710 antibiotic agent Drugs 0.000 description 3
230000003115 biocidal effect Effects 0.000 description 3
239000000872 buffer Substances 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
238000003776 cleavage reaction Methods 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
230000007613 environmental effect Effects 0.000 description 3
239000012634 fragment Substances 0.000 description 3
238000013467 fragmentation Methods 0.000 description 3
238000006062 fragmentation reaction Methods 0.000 description 3
101150054895 ftsH gene Proteins 0.000 description 3
230000002068 genetic effect Effects 0.000 description 3
238000003205 genotyping method Methods 0.000 description 3
239000011521 glass Substances 0.000 description 3
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
108010064177 glutamine synthetase I Proteins 0.000 description 3
101150097303 glyA gene Proteins 0.000 description 3
101150079604 glyA1 gene Proteins 0.000 description 3
101150028210 groEL1 gene Proteins 0.000 description 3
229940047650 haemophilus influenzae Drugs 0.000 description 3
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
230000006872 improvement Effects 0.000 description 3
238000003780 insertion Methods 0.000 description 3
230000037431 insertion Effects 0.000 description 3
238000009434 installation Methods 0.000 description 3
239000003456 ion exchange resin Substances 0.000 description 3
229920003303 ion-exchange polymer Polymers 0.000 description 3
241001515942 marmosets Species 0.000 description 3
125000003835 nucleoside group Chemical group 0.000 description 3
230000007918 pathogenicity Effects 0.000 description 3
102000054765 polymorphisms of proteins Human genes 0.000 description 3
230000002265 prevention Effects 0.000 description 3
239000002987 primer (paints) Substances 0.000 description 3
239000011541 reaction mixture Substances 0.000 description 3
230000007017 scission Effects 0.000 description 3
230000035945 sensitivity Effects 0.000 description 3
238000004611 spectroscopical analysis Methods 0.000 description 3
108700012359 toxins Proteins 0.000 description 3
230000007704 transition Effects 0.000 description 3
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
CSEBNABAWMZWIF-UHFFFAOYSA-N 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propanoic acid Chemical compound OC(=O)C(F)(C(F)(F)F)OC(F)(F)C(F)(F)C(F)(F)F CSEBNABAWMZWIF-UHFFFAOYSA-N 0.000 description 2
UJBCLAXPPIDQEE-UHFFFAOYSA-N 5-prop-1-ynyl-1h-pyrimidine-2,4-dione Chemical compound CC#CC1=CNC(=O)NC1=O UJBCLAXPPIDQEE-UHFFFAOYSA-N 0.000 description 2
QNNARSZPGNJZIX-UHFFFAOYSA-N 6-amino-5-prop-1-ynyl-1h-pyrimidin-2-one Chemical compound CC#CC1=CNC(=O)N=C1N QNNARSZPGNJZIX-UHFFFAOYSA-N 0.000 description 2
LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 2
229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 2
241000272814 Anser sp. Species 0.000 description 2
108010037870 Anthranilate Synthase Proteins 0.000 description 2
101000787278 Arabidopsis thaliana Valine-tRNA ligase, chloroplastic/mitochondrial 2 Proteins 0.000 description 2
101000787296 Arabidopsis thaliana Valine-tRNA ligase, mitochondrial 1 Proteins 0.000 description 2
238000012935 Averaging Methods 0.000 description 2
241000588807 Bordetella Species 0.000 description 2
101710117542 Botulinum neurotoxin type A Proteins 0.000 description 2
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
241000711573 Coronaviridae Species 0.000 description 2
241001445332 Coxiella <snail> Species 0.000 description 2
108090000323 DNA Topoisomerases Proteins 0.000 description 2
102000003915 DNA Topoisomerases Human genes 0.000 description 2
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
101710088194 Dehydrogenase Proteins 0.000 description 2
101000787280 Dictyostelium discoideum Probable valine-tRNA ligase, mitochondrial Proteins 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
241001646716 Escherichia coli K-12 Species 0.000 description 2
241001646719 Escherichia coli O157:H7 Species 0.000 description 2
241000589601 Francisella Species 0.000 description 2
108010036781 Fumarate Hydratase Proteins 0.000 description 2
102100036160 Fumarate hydratase, mitochondrial Human genes 0.000 description 2
241000233866 Fungi Species 0.000 description 2
208000020875 Idiopathic pulmonary arterial hypertension Diseases 0.000 description 2
102100034343 Integrase Human genes 0.000 description 2
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
108010052285 Membrane Proteins Proteins 0.000 description 2
102000018697 Membrane Proteins Human genes 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
102000006746 NADH Dehydrogenase Human genes 0.000 description 2
108010086428 NADH Dehydrogenase Proteins 0.000 description 2
238000012408 PCR amplification Methods 0.000 description 2
229930182555 Penicillin Natural products 0.000 description 2
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
108010049977 Peptide Elongation Factor Tu Proteins 0.000 description 2
102000011755 Phosphoglycerate Kinase Human genes 0.000 description 2
108091000080 Phosphotransferase Proteins 0.000 description 2
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
102000004208 Ribosomal protein L2 Human genes 0.000 description 2
108090000775 Ribosomal protein L2 Proteins 0.000 description 2
101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 description 2
102000004357 Transferases Human genes 0.000 description 2
108090000992 Transferases Proteins 0.000 description 2
DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
102000013625 Valine-tRNA Ligase Human genes 0.000 description 2
241000607598 Vibrio Species 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
108010039040 adenine glycosylase Proteins 0.000 description 2
235000012538 ammonium bicarbonate Nutrition 0.000 description 2
239000001099 ammonium carbonate Substances 0.000 description 2
239000000427 antigen Substances 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
229940009098 aspartate Drugs 0.000 description 2
230000008901 benefit Effects 0.000 description 2
230000005540 biological transmission Effects 0.000 description 2
238000004422 calculation algorithm Methods 0.000 description 2
239000002775 capsule Substances 0.000 description 2
230000032823 cell division Effects 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000004807 desolvation Methods 0.000 description 2
XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 2
235000011180 diphosphates Nutrition 0.000 description 2
238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 2
108010056732 factor EF-P Proteins 0.000 description 2
101150106096 gltA gene Proteins 0.000 description 2
101150042350 gltA2 gene Proteins 0.000 description 2
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
238000000126 in silico method Methods 0.000 description 2
238000000752 ionisation method Methods 0.000 description 2
238000007834 ligase chain reaction Methods 0.000 description 2
239000007788 liquid Substances 0.000 description 2
238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 2
108020004999 messenger RNA Proteins 0.000 description 2
230000002503 metabolic effect Effects 0.000 description 2
239000003595 mist Substances 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
229940049954 penicillin Drugs 0.000 description 2
230000002085 persistent effect Effects 0.000 description 2
150000002991 phenoxazines Chemical class 0.000 description 2
102000020233 phosphotransferase Human genes 0.000 description 2
239000002243 precursor Substances 0.000 description 2
238000012545 processing Methods 0.000 description 2
235000019833 protease Nutrition 0.000 description 2
230000005180 public health Effects 0.000 description 2
238000000746 purification Methods 0.000 description 2
230000008439 repair process Effects 0.000 description 2
208000023504 respiratory system disease Diseases 0.000 description 2
108091008146 restriction endonucleases Proteins 0.000 description 2
238000012216 screening Methods 0.000 description 2
238000010845 search algorithm Methods 0.000 description 2
238000000926 separation method Methods 0.000 description 2
239000000243 solution Substances 0.000 description 2
238000010183 spectrum analysis Methods 0.000 description 2
239000000725 suspension Substances 0.000 description 2
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
101150021331 toxR gene Proteins 0.000 description 2
238000013518 transcription Methods 0.000 description 2
230000035897 transcription Effects 0.000 description 2
238000012546 transfer Methods 0.000 description 2
UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 2
239000000304 virulence factor Substances 0.000 description 2
230000007923 virulence factor Effects 0.000 description 2
230000004304 visual acuity Effects 0.000 description 2
102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
QLOCVMVCRJOTTM-TURQNECASA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-prop-1-ynylpyrimidine-2,4-dione Chemical group O=C1NC(=O)C(C#CC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 QLOCVMVCRJOTTM-TURQNECASA-N 0.000 description 1
108010030844 2-methylcitrate synthase Proteins 0.000 description 1
HCGYMSSYSAKGPK-UHFFFAOYSA-N 2-nitro-1h-indole Chemical class C1=CC=C2NC([N+](=O)[O-])=CC2=C1 HCGYMSSYSAKGPK-UHFFFAOYSA-N 0.000 description 1
102100026105 3-ketoacyl-CoA thiolase, mitochondrial Human genes 0.000 description 1
LOJNBPNACKZWAI-UHFFFAOYSA-N 3-nitro-1h-pyrrole Chemical compound [O-][N+](=O)C=1C=CNC=1 LOJNBPNACKZWAI-UHFFFAOYSA-N 0.000 description 1
XXSIICQLPUAUDF-TURQNECASA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-prop-1-ynylpyrimidin-2-one Chemical compound O=C1N=C(N)C(C#CC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 XXSIICQLPUAUDF-TURQNECASA-N 0.000 description 1
WSGURAYTCUVDQL-UHFFFAOYSA-N 5-nitro-1h-indazole Chemical compound [O-][N+](=O)C1=CC=C2NN=CC2=C1 WSGURAYTCUVDQL-UHFFFAOYSA-N 0.000 description 1
OZFPSOBLQZPIAV-UHFFFAOYSA-N 5-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=C2NC=CC2=C1 OZFPSOBLQZPIAV-UHFFFAOYSA-N 0.000 description 1
MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
108010006229 Acetyl-CoA C-acetyltransferase Proteins 0.000 description 1
241000590020 Achromobacter Species 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
102100032534 Adenosine kinase Human genes 0.000 description 1
108020000543 Adenylate kinase Proteins 0.000 description 1
102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
108700028369 Alleles Proteins 0.000 description 1
208000037540 Alveolar soft tissue sarcoma Diseases 0.000 description 1
102000004118 Ammonia-Lyases Human genes 0.000 description 1
108090000673 Ammonia-Lyases Proteins 0.000 description 1
108010065272 Aspartate-tRNA ligase Proteins 0.000 description 1
102100028820 Aspartate-tRNA ligase, cytoplasmic Human genes 0.000 description 1
102100032948 Aspartoacylase Human genes 0.000 description 1
101100400594 Azotobacter chroococcum mcd 1 hupL gene Proteins 0.000 description 1
101100508000 Azotobacter chroococcum mcd 1 hypB gene Proteins 0.000 description 1
241000193388 Bacillus thuringiensis Species 0.000 description 1
108010077805 Bacterial Proteins Proteins 0.000 description 1
108020004513 Bacterial RNA Proteins 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
108010029692 Bisphosphoglycerate mutase Proteins 0.000 description 1
241000588832 Bordetella pertussis Species 0.000 description 1
101100439426 Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110) groEL4 gene Proteins 0.000 description 1
101100311260 Caenorhabditis elegans sti-1 gene Proteins 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
229930186147 Cephalosporin Natural products 0.000 description 1
101710104159 Chaperonin GroEL Proteins 0.000 description 1
241000606153 Chlamydia trachomatis Species 0.000 description 1
108010071536 Citrate (Si)-synthase Proteins 0.000 description 1
102000006732 Citrate synthase Human genes 0.000 description 1
241000193155 Clostridium botulinum Species 0.000 description 1
108020004705 Codon Proteins 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
241000186227 Corynebacterium diphtheriae Species 0.000 description 1
241001522132 Corynebacterium pseudodiphtheriticum Species 0.000 description 1
IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
238000007399 DNA isolation Methods 0.000 description 1
238000000018 DNA microarray Methods 0.000 description 1
238000001712 DNA sequencing Methods 0.000 description 1
241000450599 DNA viruses Species 0.000 description 1
230000004568 DNA-binding Effects 0.000 description 1
241000408659 Darpa Species 0.000 description 1
206010059866 Drug resistance Diseases 0.000 description 1
241000588877 Eikenella Species 0.000 description 1
241000305071 Enterobacterales Species 0.000 description 1
101100172469 Escherichia coli (strain K12) envZ gene Proteins 0.000 description 1
102100040004 Gamma-glutamylcyclotransferase Human genes 0.000 description 1
108010021582 Glucokinase Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
108700016167 Glutamate racemases Proteins 0.000 description 1
108010043428 Glycine hydroxymethyltransferase Proteins 0.000 description 1
108010004889 Heat-Shock Proteins Proteins 0.000 description 1
102000002812 Heat-Shock Proteins Human genes 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000797251 Homo sapiens Aspartoacylase Proteins 0.000 description 1
101000886680 Homo sapiens Gamma-glutamylcyclotransferase Proteins 0.000 description 1
102000006933 Hydroxymethyl and Formyl Transferases Human genes 0.000 description 1
108010072462 Hydroxymethyl and Formyl Transferases Proteins 0.000 description 1
229930010555 Inosine Natural products 0.000 description 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
101710198693 Invasin Proteins 0.000 description 1
241000588748 Klebsiella Species 0.000 description 1
241000588747 Klebsiella pneumoniae Species 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
108010006519 Molecular Chaperones Proteins 0.000 description 1
241000588621 Moraxella Species 0.000 description 1
KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
101710138657 Neurotoxin Proteins 0.000 description 1
206010029803 Nosocomial infection Diseases 0.000 description 1
108091028043 Nucleic acid sequence Proteins 0.000 description 1
238000010222 PCR analysis Methods 0.000 description 1
201000005702 Pertussis Diseases 0.000 description 1
102000011025 Phosphoglycerate Mutase Human genes 0.000 description 1
206010035664 Pneumonia Diseases 0.000 description 1
229940123573 Protein synthesis inhibitor Drugs 0.000 description 1
241000192142 Proteobacteria Species 0.000 description 1
108090001066 Racemases and epimerases Proteins 0.000 description 1
102000004879 Racemases and epimerases Human genes 0.000 description 1
101000713302 Rattus norvegicus Sodium-coupled neutral amino acid transporter 1 Proteins 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
102000018120 Recombinases Human genes 0.000 description 1
108010091086 Recombinases Proteins 0.000 description 1
108020001027 Ribosomal DNA Proteins 0.000 description 1
101100231695 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FRT1 gene Proteins 0.000 description 1
SZKKRCSOSQAJDE-UHFFFAOYSA-N Schradan Chemical compound CN(C)P(=O)(N(C)C)OP(=O)(N(C)C)N(C)C SZKKRCSOSQAJDE-UHFFFAOYSA-N 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
102000019394 Serine hydroxymethyltransferases Human genes 0.000 description 1
108010079723 Shiga Toxin Proteins 0.000 description 1
241000607768 Shigella Species 0.000 description 1
241000191963 Staphylococcus epidermidis Species 0.000 description 1
241001134658 Streptococcus mitis Species 0.000 description 1
241000194025 Streptococcus oralis Species 0.000 description 1
241000193998 Streptococcus pneumoniae Species 0.000 description 1
241000194051 Streptococcus vestibularis Species 0.000 description 1
108010006785 Taq Polymerase Proteins 0.000 description 1
208000009979 Traumatic Amputation Diseases 0.000 description 1
108010057266 Type A Botulinum Toxins Proteins 0.000 description 1
HSCJRCZFDFQWRP-JZMIEXBBSA-N UDP-alpha-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-JZMIEXBBSA-N 0.000 description 1
IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 1
HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 description 1
241000700647 Variola virus Species 0.000 description 1
108010027570 Xanthine phosphoribosyltransferase Proteins 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
102000005421 acetyltransferase Human genes 0.000 description 1
108020002494 acetyltransferase Proteins 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine group Chemical group [C@@H]1([C@H](O)[C@H](O)[C@@H](CO)O1)N1C=NC=2C(N)=NC=NC12 OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 1
230000002411 adverse Effects 0.000 description 1
208000008524 alveolar soft part sarcoma Diseases 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
230000037354 amino acid metabolism Effects 0.000 description 1
238000000137 annealing Methods 0.000 description 1
RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 1
230000003466 anti-cipated effect Effects 0.000 description 1
230000000340 anti-metabolite Effects 0.000 description 1
238000009635 antibiotic susceptibility testing Methods 0.000 description 1
229940100197 antimetabolite Drugs 0.000 description 1
239000002256 antimetabolite Substances 0.000 description 1
238000013459 approach Methods 0.000 description 1
238000003491 array Methods 0.000 description 1
229940097012 bacillus thuringiensis Drugs 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
230000037429 base substitution Effects 0.000 description 1
DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
229960003237 betaine Drugs 0.000 description 1
230000027455 binding Effects 0.000 description 1
239000006161 blood agar Substances 0.000 description 1
229940015062 campylobacter jejuni Drugs 0.000 description 1
229940124587 cephalosporin Drugs 0.000 description 1
150000001780 cephalosporins Chemical class 0.000 description 1
150000001793 charged compounds Chemical class 0.000 description 1
229940038705 chlamydia trachomatis Drugs 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
108091036078 conserved sequence Proteins 0.000 description 1
238000010276 construction Methods 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
238000011109 contamination Methods 0.000 description 1
238000012258 culturing Methods 0.000 description 1
101150084863 cya gene Proteins 0.000 description 1
229940095074 cyclic amp Drugs 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
239000003599 detergent Substances 0.000 description 1
238000011161 development Methods 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
238000009826 distribution Methods 0.000 description 1
241001493065 dsRNA viruses Species 0.000 description 1
238000001425 electrospray ionisation time-of-flight mass spectrometry Methods 0.000 description 1
238000011067 equilibration Methods 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000010265 fast atom bombardment Methods 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
235000013305 food Nutrition 0.000 description 1
239000007789 gas Substances 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
239000008103 glucose Substances 0.000 description 1
229930195712 glutamate Natural products 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
239000010931 gold Substances 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
101150082480 gtr gene Proteins 0.000 description 1
101150070420 gyrA gene Proteins 0.000 description 1
101150013736 gyrB gene Proteins 0.000 description 1
229920006158 high molecular weight polymer Polymers 0.000 description 1
101150059304 hup gene Proteins 0.000 description 1
101150098043 hupB gene Proteins 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
230000036039 immunity Effects 0.000 description 1
238000012405 in silico analysis Methods 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
101150016780 infB gene Proteins 0.000 description 1
239000012678 infectious agent Substances 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
229960003786 inosine Drugs 0.000 description 1
230000009545 invasion Effects 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
238000005040 ion trap Methods 0.000 description 1
ODBLHEXUDAPZAU-UHFFFAOYSA-N isocitric acid Chemical compound OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
238000002955 isolation Methods 0.000 description 1
101150005373 lef gene Proteins 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
230000037356 lipid metabolism Effects 0.000 description 1
238000007403 mPCR Methods 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
239000006148 magnetic separator Substances 0.000 description 1
238000000691 measurement method Methods 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
239000012528 membrane Substances 0.000 description 1
229960003085 meticillin Drugs 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
230000033607 mismatch repair Effects 0.000 description 1
101150029137 mutY gene Proteins 0.000 description 1
239000002581 neurotoxin Substances 0.000 description 1
231100000618 neurotoxin Toxicity 0.000 description 1
238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 1
239000003865 nucleic acid synthesis inhibitor Substances 0.000 description 1
230000037360 nucleotide metabolism Effects 0.000 description 1
101150047779 ompB gene Proteins 0.000 description 1
101150091444 ompR gene Proteins 0.000 description 1
101150012629 parE gene Proteins 0.000 description 1
244000045947 parasite Species 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
239000012071 phase Substances 0.000 description 1
KCRZDTROFIOPBP-UHFFFAOYSA-N phosphono 2,3-dihydroxypropanoate Chemical compound OCC(O)C(=O)OP(O)(O)=O KCRZDTROFIOPBP-UHFFFAOYSA-N 0.000 description 1
238000013081 phylogenetic analysis Methods 0.000 description 1
239000013641 positive control Substances 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
239000000007 protein synthesis inhibitor Substances 0.000 description 1
150000003212 purines Chemical class 0.000 description 1
150000003230 pyrimidines Chemical class 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
239000011535 reaction buffer Substances 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000005215 recombination Methods 0.000 description 1
230000010076 replication Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
210000003705 ribosome Anatomy 0.000 description 1
230000028327 secretion Effects 0.000 description 1
239000006152 selective media Substances 0.000 description 1
238000010532 solid phase synthesis reaction Methods 0.000 description 1
239000002904 solvent Substances 0.000 description 1
230000003595 spectral effect Effects 0.000 description 1
239000007921 spray Substances 0.000 description 1
229940031000 streptococcus pneumoniae Drugs 0.000 description 1
230000008685 targeting Effects 0.000 description 1
238000012360 testing method Methods 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
238000001269 time-of-flight mass spectrometry Methods 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
238000012549 training Methods 0.000 description 1
230000014616 translation Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
230000001960 triggered effect Effects 0.000 description 1
125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
229940045145 uridine Drugs 0.000 description 1
238000003260 vortexing Methods 0.000 description 1
101150040194 waaA gene Proteins 0.000 description 1
229940075420 xanthine Drugs 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Analytical Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

CA2560521A 2004-02-18 2005-02-18 Compositions destinees a l'identification de bacteries Expired - Fee Related CA2560521C (fr)

Applications Claiming Priority (11)

Application Number	Priority Date	Filing Date	Title
US54542504P	2004-02-18	2004-02-18
US60/545,425		2004-02-18
US55975404P	2004-04-05	2004-04-05
US60/559,754		2004-04-05
US63286204P	2004-12-03	2004-12-03
US60/632,862		2004-12-03
US63906804P	2004-12-22	2004-12-22
US60/639,068		2004-12-22
US64818805P	2005-01-28	2005-01-28
US60/648,188		2005-01-28
PCT/US2005/006133 WO2006071241A2 (fr)	2004-02-18	2005-02-18	Compositions destinees a l'identification de bacteries

Publications (2)

Publication Number	Publication Date
CA2560521A1 CA2560521A1 (fr)	2006-07-06
CA2560521C true CA2560521C (fr)	2012-01-03

Family

ID=35125687

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2560521A Expired - Fee Related CA2560521C (fr)	2004-02-18	2005-02-18	Compositions destinees a l'identification de bacteries

Country Status (5)

Country	Link
EP (1)	EP1725686A4 (fr)
JP (1)	JP2007525978A (fr)
AU (2)	AU2005322640B2 (fr)
CA (1)	CA2560521C (fr)
WO (2)	WO2006071241A2 (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2009155061A2 (fr) *	2008-05-30	2009-12-23	Ibis Biosciences, Inc.	Compositions à utiliser pour identifier des souches d'e. coli o157:h7
US20030027135A1 (en)	2001-03-02	2003-02-06	Ecker David J.	Method for rapid detection and identification of bioagents
US7226739B2 (en)	2001-03-02	2007-06-05	Isis Pharmaceuticals, Inc	Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US20040121309A1 (en)	2002-12-06	2004-06-24	Ecker David J.	Methods for rapid detection and identification of bioagents in blood, bodily fluids, and bodily tissues
US7666588B2 (en)	2001-03-02	2010-02-23	Ibis Biosciences, Inc.	Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
CA2348042A1 (fr)	2001-06-04	2002-12-04	Ann Huletsky	Sequences permettant de detecter et d'identifier des staphylococcus aureus resistant a la meticilline
US7217510B2 (en)	2001-06-26	2007-05-15	Isis Pharmaceuticals, Inc.	Methods for providing bacterial bioagent characterizing information
US8073627B2 (en)	2001-06-26	2011-12-06	Ibis Biosciences, Inc.	System for indentification of pathogens
JP2006516193A (ja)	2002-12-06	2006-06-29	アイシス・ファーマシューティカルス・インコーポレーテッド	ヒトおよび動物における病原体の迅速な同定方法
US8057993B2 (en)	2003-04-26	2011-11-15	Ibis Biosciences, Inc.	Methods for identification of coronaviruses
US8158354B2 (en)	2003-05-13	2012-04-17	Ibis Biosciences, Inc.	Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US7964343B2 (en)	2003-05-13	2011-06-21	Ibis Biosciences, Inc.	Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8097416B2 (en)	2003-09-11	2012-01-17	Ibis Biosciences, Inc.	Methods for identification of sepsis-causing bacteria
US8546082B2 (en)	2003-09-11	2013-10-01	Ibis Biosciences, Inc.	Methods for identification of sepsis-causing bacteria
US7956175B2 (en)	2003-09-11	2011-06-07	Ibis Biosciences, Inc.	Compositions for use in identification of bacteria
US7666592B2 (en)	2004-02-18	2010-02-23	Ibis Biosciences, Inc.	Methods for concurrent identification and quantification of an unknown bioagent
EP2458619B1 (fr)	2004-05-24	2017-08-02	Ibis Biosciences, Inc.	Spectrométrie de masse avec filtration sélective d'ions par établissement de seuils numériques
US20050266411A1 (en)	2004-05-25	2005-12-01	Hofstadler Steven A	Methods for rapid forensic analysis of mitochondrial DNA
US7811753B2 (en)	2004-07-14	2010-10-12	Ibis Biosciences, Inc.	Methods for repairing degraded DNA
WO2006135400A2 (fr)	2004-08-24	2006-12-21	Isis Pharmaceuticals, Inc.	Procedes pour l'identification rapide d'organismes recombinants
WO2006094238A2 (fr)	2005-03-03	2006-09-08	Isis Pharmaceuticals, Inc.	Compositions utilisees pour identifier des virus secondaires
US8084207B2 (en)	2005-03-03	2011-12-27	Ibis Bioscience, Inc.	Compositions for use in identification of papillomavirus
CA2616281C (fr)	2005-07-21	2014-04-22	Isis Pharmaceuticals, Inc.	Procede pour l'identification et la quantification rapide de variants d'acide nucleique
US11834720B2 (en)	2005-10-11	2023-12-05	Geneohm Sciences, Inc.	Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA) of MREJ types xi to xx
BRPI0605802A (pt) *	2005-11-21	2007-09-04	Biosigma Sa	método e arranjo para detectar e indentificar os microorganismos presentes em uma amostra usando as regiões genÈmicas que codificam para as distintas rnat sintetases
JP5420412B2 (ja)	2006-09-14	2014-02-19	アイビスバイオサイエンシズインコーポレイティッド	病原体の同定のための標的全ゲノム増幅方法
JP5680304B2 (ja)	2007-02-23	2015-03-04	アイビスバイオサイエンシズインコーポレイティッド	迅速な法医学的ｄｎａ分析法
EP1997905A1 (fr) *	2007-06-01	2008-12-03	Friesland Brands B.V.	Amplification d'acide nucléique
US9598724B2 (en)	2007-06-01	2017-03-21	Ibis Biosciences, Inc.	Methods and compositions for multiple displacement amplification of nucleic acids
EP2344893B1 (fr)	2008-09-16	2014-10-15	Ibis Biosciences, Inc.	Systèmes et procédés de manipulation de microplaques
WO2010033599A2 (fr)	2008-09-16	2010-03-25	Ibis Biosciences, Inc.	Cartouches de mélange, postes de mélange et kits, systèmes et procédés associés
US8148163B2 (en)	2008-09-16	2012-04-03	Ibis Biosciences, Inc.	Sample processing units, systems, and related methods
US20110183345A1 (en) *	2008-10-03	2011-07-28	Ibis Biosciences, Inc.	Compositions for use in identification of streptococcus pneumoniae
EP2396803A4 (fr)	2009-02-12	2016-10-26	Ibis Biosciences Inc	Ensembles sonde d'ionisation
WO2010114842A1 (fr)	2009-03-30	2010-10-07	Ibis Biosciences, Inc.	Systèmes, dispositifs et procédés de détection d'agent biologique
US9194877B2 (en)	2009-07-17	2015-11-24	Ibis Biosciences, Inc.	Systems for bioagent indentification
US8950604B2 (en)	2009-07-17	2015-02-10	Ibis Biosciences, Inc.	Lift and mount apparatus
WO2011014811A1 (fr)	2009-07-31	2011-02-03	Ibis Biosciences, Inc.	Amorces de capture et supports solides liés à une séquence de capture pour tests diagnostiques moléculaires
ES2628739T3 (es)	2009-10-15	2017-08-03	Ibis Biosciences, Inc.	Amplificación por desplazamiento múltiple
US20110224106A1 (en)	2010-03-10	2011-09-15	Ibis Biosciences, Inc.	Production Of Single-Stranded Circular Nucleic Acid
US9068017B2 (en)	2010-04-08	2015-06-30	Ibis Biosciences, Inc.	Compositions and methods for inhibiting terminal transferase activity
EP2753629B1 (fr)	2011-09-06	2016-10-19	Ibis Biosciences, Inc.	Procédé pour détecter la maladie de lyme
WO2013101935A1 (fr)	2011-12-27	2013-07-04	Ibis Biosciences, Inc.	Oligonucléotides pour la détection d'agent biologique
JP2013171343A (ja)	2012-02-17	2013-09-02	Toshiba Corp	ストレージデバイス
WO2014052590A1 (fr)	2012-09-26	2014-04-03	Ibis Biosciences, Inc.	Dispositifs permettant de mettre en interface un écouvillon avec un dispositif microfluidique ainsi que trousses, systèmes et procédés associés
US12379382B2 (en) *	2018-09-28	2025-08-05	Keio University	Analysis method, analytical method and microorganism identification method
RU2765495C1 (ru) *	2021-05-31	2022-01-31	Федеральное казенное учреждение здравоохранения "Ростовский-на-Дону ордена Трудового Красного Знамени научно-исследовательский противочумный институт" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека	Способ определения подвидов Francisella tularensis методом мультипраймерной ПЦР
WO2022271860A2 (fr) *	2021-06-22	2022-12-29	Janus-I Science Inc.	Procédé d'analyse large de micro-organismes et de déterminants de résistance aux médicaments dans des échantillons provenant d'un sujet et dispositifs correspondants

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5849492A (en) *	1994-02-28	1998-12-15	Phylogenetix Laboratories, Inc.	Method for rapid identification of prokaryotic and eukaryotic organisms
US6503709B1 (en) *	1997-07-03	2003-01-07	Id Biomedical Corporation	Methods for rapidly detecting methicillin resistant staphylococci
KR100395181B1 (ko) *	1997-08-26	2003-08-21	미츠비시 스미토모 실리콘 주식회사	고품질 실리콘 단결정 및 그 제조방법
US6613509B1 (en) *	1999-03-22	2003-09-02	Regents Of The University Of California	Determination of base (nucleotide) composition in DNA oligomers by mass spectrometry
WO2002016649A2 (fr) *	2000-08-25	2002-02-28	Illumina, Inc.	Sondes et oligonucleotides decodeurs
US20030027135A1 (en) *	2001-03-02	2003-02-06	Ecker David J.	Method for rapid detection and identification of bioagents
US20040121309A1 (en) *	2002-12-06	2004-06-24	Ecker David J.	Methods for rapid detection and identification of bioagents in blood, bodily fluids, and bodily tissues
JP2003061665A (ja) *	2001-08-21	2003-03-04	Yakult Bio-Science Foundation	芽胞形成菌の検出方法

2005
- 2005-02-18 CA CA2560521A patent/CA2560521C/fr not_active Expired - Fee Related
- 2005-02-18 AU AU2005322640A patent/AU2005322640B2/en not_active Ceased
- 2005-02-18 WO PCT/US2005/006133 patent/WO2006071241A2/fr not_active Ceased
- 2005-02-18 JP JP2006554339A patent/JP2007525978A/ja active Pending
- 2005-02-18 EP EP05856582A patent/EP1725686A4/fr not_active Withdrawn
- 2005-02-18 WO PCT/US2005/005356 patent/WO2005098047A2/fr not_active Ceased
2008
- 2008-12-12 AU AU2008255266A patent/AU2008255266B2/en not_active Ceased

Also Published As

Publication number	Publication date
EP1725686A2 (fr)	2006-11-29
WO2006071241A3 (fr)	2007-09-13
CA2560521A1 (fr)	2006-07-06
WO2006071241A2 (fr)	2006-07-06
WO2005098047A2 (fr)	2005-10-20
WO2005098047A3 (fr)	2007-10-04
JP2007525978A (ja)	2007-09-13
AU2008255266A1 (en)	2009-01-08
AU2005322640A1 (en)	2006-07-06
EP1725686A4 (fr)	2008-12-10
AU2008255266B2 (en)	2011-07-14
AU2005322640B2 (en)	2008-09-18

Legal Events

Date	Code	Title	Description
2006-09-19	EEER	Examination request
2015-04-01	MKLA	Lapsed	Effective date: 20150218

Publication	Publication Date	Title
CA2560521C (fr)	2012-01-03	Compositions destinees a l'identification de bacteries
US8013142B2 (en)	2011-09-06	Compositions for use in identification of bacteria
EP1882045B1 (fr)	2012-08-29	COMPOSITION A UTILISER DANS L'IDENTIFICATION DE Staphylococcus aureus
US8097416B2 (en)	2012-01-17	Methods for identification of sepsis-causing bacteria
US8546082B2 (en)	2013-10-01	Methods for identification of sepsis-causing bacteria
US20080138808A1 (en)	2008-06-12	Methods for identification of sepsis-causing bacteria
US20100204266A1 (en)	2010-08-12	Compositions for use in identification of mixed populations of bioagents
US20080146455A1 (en)	2008-06-19	Methods for identification of sepsis-causing bacteria
WO2009017902A2 (fr)	2009-02-05	Compositions et procédés permettant d'identifier des caractéristiques de sous-espèces de mycobacterium tuberculosis
US20110105531A1 (en)	2011-05-05	Compositions and methods for identification of subspecies characteristics of mycobacterium tuberculosis
US20120171692A1 (en)	2012-07-05	Composition For Use In Identification Of Bacteria
US20110256541A1 (en)	2011-10-20	Compositions for use in identification of bacteria
AU2013267065B2 (en)	2015-07-30	Methods for rapid identification of pathogens in humans and animals